44 related articles for article (PubMed ID: 34727247)
1. Imaging and Management of Fibroepithelial Lesions of the Breast: Radiologic-Pathologic Correlation.
Zhang M; Arjmandi FK; Porembka JH; Seiler SJ; Goudreau SH; Merchant K; Hwang H; Hayes JC
Radiographics; 2023 Nov; 43(11):e230051. PubMed ID: 37856317
[TBL] [Abstract][Full Text] [Related]
2. Fibroepithelial Lesions in the Breast of Adolescent Females: A Clinicopathological Study of 54 Cases.
Ross DS; Giri DD; Akram MM; Catalano JP; Olcese C; Van Zee KJ; Brogi E
Breast J; 2017 Mar; 23(2):182-192. PubMed ID: 28299887
[TBL] [Abstract][Full Text] [Related]
3. Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.
Piscuoglio S; Ng CK; Murray M; Burke KA; Edelweiss M; Geyer FC; Macedo GS; Inagaki A; Papanastasiou AD; Martelotto LG; Marchio C; Lim RS; Ioris RA; Nahar PK; Bruijn ID; Smyth L; Akram M; Ross D; Petrini JH; Norton L; Solit DB; Baselga J; Brogi E; Ladanyi M; Weigelt B; Reis-Filho JS
J Pathol; 2016 Mar; 238(4):508-18. PubMed ID: 26832993
[TBL] [Abstract][Full Text] [Related]
4. Precise diagnosis of breast phyllodes tumors using Raman spectroscopy: Biochemical fingerprint, tumor metabolism and possible mechanism.
Wu Y; Wang Y; He C; Wang Y; Ma J; Lin Y; Zhou L; Xu S; Ye Y; Yin W; Ye J; Lu J
Anal Chim Acta; 2023 Dec; 1283():341897. PubMed ID: 37977771
[TBL] [Abstract][Full Text] [Related]
5. Stromal Ki67 Expression Might be a Useful Marker for Distinguishing Fibroadenoma From Benign Phyllodes Tumor of the Breast.
Yuan M; Saeki H; Horimoto Y; Ishizuka Y; Onagi H; Saito M; Hayashi T; Arakawa A; Yao T
Int J Surg Pathol; 2024 Apr; 32(2):223-229. PubMed ID: 37157807
[No Abstract] [Full Text] [Related]
6. Are both distinct epithelial and stromal cells molecular analysis from phyllodes tumors versus fibroadenoma components affected in breast fibroepithelial progression?
Waitzberg ÂFL; Ferreira ENE; Pinilla M; Pineda P; Malinverni ACM; Soares FA; Carraro DM
Acta Cir Bras; 2023; 38():e386823. PubMed ID: 38055384
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing Fibroepithelial Lesions Requires Clinical, Imaging, and Pathology Correlation.
Bradley M; Miles B; Young P; He J; Nguyen QD
Cureus; 2023 Oct; 15(10):e47673. PubMed ID: 38021664
[TBL] [Abstract][Full Text] [Related]
8. Integrated multi-omics profiling reveals a clinically relevant molecular feature and potential therapeutic target on phyllodes tumors of breast.
Xu W; Ma W; Wang D; Zhou X; Wang K; Mu K
Transl Oncol; 2024 May; 46():101998. PubMed ID: 38761630
[TBL] [Abstract][Full Text] [Related]
9. Native T1 mapping for assessment of the perilesional zone in metastases and benign lesions of the liver.
Fahlenkamp UL; Ziegeler K; Adams LC; Böker SM; Engel G; Makowski MR
Sci Rep; 2020 Jul; 10(1):12889. PubMed ID: 32733016
[TBL] [Abstract][Full Text] [Related]
10. The Genetic Landscape of Fibroepithelial Lesions of the Breast.
Dadmanesh F; Li X; Leong M; Maluf H; Balzer B
Adv Anat Pathol; 2023 Nov; 30(6):415-420. PubMed ID: 37539688
[TBL] [Abstract][Full Text] [Related]
11. Malignant transformation of phyllodes tumor: a case report and review of literature.
Pornchai S; Chirappapha P; Pipatsakulroj W; Lertsithichai P; Vassanasiri W; Sitathanee C; Kongdan Y; Sukarayothin T; Leesombatpaiboon M
Clin Case Rep; 2018 Apr; 6(4):678-685. PubMed ID: 29636939
[TBL] [Abstract][Full Text] [Related]
12. Magnetic Resonance Imaging of a Benign Phyllodes Tumor of the Breast.
Balaji R; Ramachandran KN
Breast Care (Basel); 2009; 4(3):189-191. PubMed ID: 20847879
[TBL] [Abstract][Full Text] [Related]
13. T
Payne MM; Mali I; Shrestha TB; Basel MT; Timmerman S; Pyle M; Sebek J; Prakash P; Bossmann SH
Biophys Rep (N Y); 2024 May; ():100157. PubMed ID: 38795740
[TBL] [Abstract][Full Text] [Related]
14. Cellular
Bober Z; Podgórski R; Aebisher D; Cieślar G; Kawczyk-Krupka A; Bartusik-Aebisher D
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902163
[TBL] [Abstract][Full Text] [Related]
15. Native T1 mapping of the breast in MRI to differentiate fibroadenomas from benign phyllodes tumors: a preliminary study.
Yalcin A; Goktepeli M; Taydas O; Sayar I
MAGMA; 2022 Jun; 35(3):441-447. PubMed ID: 34727247
[TBL] [Abstract][Full Text] [Related]
16. The value of whole-tumor histogram and texture analysis based on apparent diffusion coefficient (ADC) maps for the discrimination of breast fibroepithelial lesions: corresponds to clinical management decisions.
Li X; Chai W; Sun K; Fu C; Yan F
Jpn J Radiol; 2022 Dec; 40(12):1263-1271. PubMed ID: 35793052
[TBL] [Abstract][Full Text] [Related]
17. Cellular fibroepithelial lesions diagnosed on core needle biopsy: Is there any role of clinical-sonography features helping to differentiate fibroadenomas and phyllodes tumor?
Al-Arnawoot B; Scaranelo A; Fleming R; Kulkarni S; Menezes RJ; McCready D; Done S; Freitas V
J Surg Oncol; 2020 Sep; 122(3):382-387. PubMed ID: 32396665
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between Phyllodes Tumors and Fibroadenomas through Breast Ultrasound: Deep-Learning Model Outperforms Ultrasound Physicians.
Shi Z; Ma Y; Ma X; Jin A; Zhou J; Li N; Sheng D; Chang C; Chen J; Li J
Sensors (Basel); 2023 May; 23(11):. PubMed ID: 37299826
[TBL] [Abstract][Full Text] [Related]
19. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
